Leadership Team

Roy Jensen, MD Director, KU Cancer Center CEO, Midwest Cancer Alliance	Shrikant Anant, PhD Associate Director, Cancer Prevention and Control
Jeff Aubè, PhD Program Leader, Drug Discovery, Delivery and Experimental Therapeutics	Teresa Christenson Associate Director Administration
Dan Dixon, PhD Co-leader, Cancer Prevention	Edward Ellerbeck, MD, MPH Program Leader, Cancer Control & Population Health
Gary Doolittle, MD Medical Director, Midwest Cancer Alliance	Carol Fabian, MD Co-leader, Cancer Prevention
Kimberly Engelman, PhD Co-leader, Cancer Control & Population Health	Parvesh Kumar, MD Associate Director, Clinical Research
Andrew Godwin, PhD Deputy Director, The University of Kansas Cancer Center Director, Biospecimen Repository, The University of Kansas Cancer Center	Matthew Mayo, PhD Associate Director, Shared Resources
Linheng Li, PhD Co-leader, Cancer Biology	Raymond Perez, MD Director, Early Phase Clinical Trials
Kristi Neufeld, PhD Co-Leader, Cancer Biology	Terance T. Tsue, MD, FACS Physician-in-Chief, The University of Kansas Cancer Center
Jeffrey Reene, MBA Chief Operating Officer	Steve Williamson, MD Medical Director, Cancer Clinical Trials
Danny Welch, PhD Associate Director, Basic Science	Scott Weir, PharmD, PhD Director, Institute for Advancing Medical Innovation